AR
AEON.WS

Advisory Research’s AEON Biopharma Inc AEON.WS Stock Holding History

Advisory Research’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,119
Closed -$8K – 415
2022
Q2 		$8K Hold
50,119
– – ﹤0.01% 354
2022
Q1 		$14K Hold
50,119
– – ﹤0.01% 390
2021
Q4 		$26K Buy
50,119
+1,400
+3% +$774 ﹤0.01% 341
2021
Q3 		$29K Hold
48,719
– – ﹤0.01% 341
2021
Q2 		$49K Buy
+48,719
New +$37K ﹤0.01% 338

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Advisory Research's AEON.WS Position: Q3 2022 in Review

Advisory Research sold out of AEON Biopharma Inc (AEON.WS) in Q3 2022, closing a stake of 50,119 shares — an estimated $8K sold.

Advisory Research first reported a position in AEON.WS in Q2 2021 and held it in 5 quarters. The position peaked at $49K in Q2 2021. 53 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2022.

  • Advisory Research reported no remaining AEON Biopharma Inc position as of Q3 2022 after selling out during the quarter.
  • Advisory Research sold 50,119 AEON Biopharma Inc shares in Q3 2022, an estimated $8K.
  • Advisory Research first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 5 quarters.
  • Advisory Research's AEON Biopharma Inc position peaked at $49K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.